Olema Oncology

formerly Olema PharmaceuticalsIPO

Developing better medicines for breast cancer and beyond

Public · San Francisco, United States · Founded 2006 · $142.0M raised

Employees
51–200
Founded
2006
Business Model
B2B
Website
olema.com
Total Funding
$142.0M
Last Round
$3.0M Convertible NoteOct 2020
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Olema Oncology is a clinical-stage biopharmaceutical company focused on transforming the treatment paradigm for metastatic breast cancer and endocrine-driven cancers. The company's lead program, palazestrant (OP-1250), is a differentiated oral complete estrogen receptor antagonist (CERAN) in late-stage clinical development; its pipeline also includes OP-3136, a potent oral KAT6 inhibitor. Founded in 2006 and headquartered in San Francisco with operations in Cambridge, Massachusetts, Olema is a publicly traded company (Nasdaq) advancing multiple clinical trials for patients with ER+/HER2- metastatic breast cancer and other solid tumors.

Summary

Olema Oncology is a Biotech company based in San Francisco, United States, founded in 2006. It has raised $142.0M in total across 3 rounds, most recently a $3.0M Convertible Note round in Oct 2020. Investors include BVF Partners.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Secondary MarketSecondary MarketSep 2023

Sign up to see all 6 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
IVI-RMA

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...

Valencia, Spain5001–10000Biotech, Healthcare
Private EquityTotal funding$3.3BApr 2022
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Olema Oncology on Indexed.vc
<a href="https://indexed.vc/companies/olema-oncology"><img src="https://indexed.vc/api/badge/company/olema-oncology" alt="Olema Oncology on Indexed.vc" width="260" height="76" /></a>